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The underlying mechanisms in the development of diabetic nephropathy are currently
unclear and likely consist of a series of dynamic events from the early to late stages
of the disease. Diabetic nephropathy is currently without curative treatments and it is
acknowledged that even the earliest clinical manifestation of nephropathy is preceded
by an established morphological renal injury that is in turn preceded by functional and
metabolic alterations. An early manifestation of the diabetic kidney is the development
of kidney hypoxia that has been acknowledged as a common pathway to nephropathy.
There have been reports of altered mitochondrial function in the diabetic kidney such as
altered mitophagy, mitochondrial dynamics, uncoupling, and cellular signaling through
hypoxia inducible factors and AMP-kinase. These factors are also likely to be intertwined
in a complex manner. In this review, we discuss how these pathways are connected to
mitochondrial production of reactive oxygen species (ROS) and how they may relate to
the development of kidney hypoxia in diabetic nephropathy. From available literature, it
is evident that early correction and/or prevention of mitochondrial dysfunction may be
pivotal in the prevention and treatment of diabetic nephropathy.
Keywords: diabetic nephropathy, kidney hypoxia, mitochondrial function, superoxide production, mitochondrial
uncoupling, mitochondrial ROS, hypoxia inducible factors
DIABETIC NEPHROPATHY
Diabetic nephropathy accounts for∼45% of cases with end-stage renal disease (McCullough et al.,
2007) and aﬄict about 30% of patients with diabetes mellitus (Hasslacher et al., 1989). Early
diabetic nephropathy is evident as microalbuminuria (30–300 mg/day) and disease progression
is characterized by progressively worsening albuminuria, loss of glomerular filtration rate, and
structural changes such as thickening of glomerular basement membranes, extracellular matrix
accumulation, and tubulointerstitial damage (Mauer et al., 1984; Brito et al., 1998; Katz et al., 2002;
Mauer and Drummond, 2002). Currently, there are no curative treatments and disease progression
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ultimately results in requirement for renal replacement therapy
i.e., dialysis or renal transplantation.
HYPOXIA IS AN ACKNOWLEDGED
PATHWAY TO NEPHROPATHY
The oxygen levels in the kidney with oxygen tension in cortex
around 50–60 mmHg and as low as 10–20 mmHg in medulla
(Epstein et al., 1994) makes the kidney susceptible to diverse
renal pathologies. The distribution of glycolytic enzymes has a
heterogeneous pattern and are scarcely found from glomerulus
until the loop of Henle with a multifold increase in thick
ascending limb and along the rest of the nephron to the collecting
duct (Guder and Ross, 1984). The proximal tubules therefore
mainly rely on mitochondrial ATP production. However, the
glycolytic enzymes in proximal tubules can be induced in hypoxia
(Gullans et al., 1982; Dickman and Mandel, 1990). The theory
of renal hypoxia has emerged as a pathway to nephropathy. It
was suggested by Fine et al. that an initial glomerular injury
would decrease blood flow through peritubular capillaries and
decrease oxygenation, promoting tubulointerstitial fibrosis and
damage progression, ultimately resulting in nephropathy (Fine
et al., 1998). This theory is proposed to be a joint pathway
for development of nephropathy in a number of conditions
and not restricted to diabetic nephropathy alone. The chronic
hypoxia theory has gained support in experimental animal
studies (Palm et al., 2003; Ries et al., 2003; Rosenberger et al.,
2008; Edlund et al., 2009; Haidara et al., 2009) as well as in
human studies (Sayarlioglu et al., 2005; Hochman et al., 2007;
Inoue et al., 2011). Navajo Indians living at high altitude have
increased incidence of ESRD (non-diabetes-related; Hochman
et al., 2007) and in patients suffering from sleep apnea the
degree of nocturnal hypoxemia correlates with worsening kidney
function (Sakaguchi et al., 2013). Also, patients with type 2
diabetes living at high altitude had increased incidence of diabetic
nephropathy when compared to a similar patient group living
at sea level. Importantly, glycaemia, hypertension, and lipidemia
status were similar between the groups (Sayarlioglu et al., 2005).
Expertly reviewed elsewhere, the support for kidney hypoxia as a
common pathway to nephropathy is quite compelling (Nangaku,
2006; Singh et al., 2008; Mimura and Nangaku, 2010; Palm and
Nordquist, 2011).
This review will not focus on the mechanisms of hypoxia
resulting in nephropathy but rather the mechanisms that may
influence the development of hypoxia, namely mitochondrial
function and reactive oxygen species (ROS) production.
Abbreviations: AICAR, 5-Aminoimidazole-4-carboxamide ribonucleotide;
AMPK, AMP-kinase; DHE, dihydroethidium; DNA, deoxyribonucleic acid;
DRP, dynamin related protein; DLP, dynamin like protein; ETS, electron
transport system; FIS, mitochondrial fission protein; HIF, hypoxia inducible
factor; LC3-II, LC3-phosphatidylethanolamine conjugate; NF-κB, nuclear factor
kappa-light-chain-enhancer of activated B cells; mnSOD, manganese superoxide
dismutase; MnTBAP, manganese (III) tetrakis (4-benzoic acid) porphyrin
chloride; P62/SQSTM1 sequestosome 1; PARP, poly adenosine diphosphate
ribose polymerase; PGC-1α, peroxisome proliferator-activated receptor gamma
coactivator 1α; ROS, reactive oxygen species; Si, small interference; TCA,
tricarboxylic acid; UCP, uncoupling protein.
MITOCHONDRIAL PRODUCTION OF
REACTIVE OXYGEN SPECIES IN THE
DIABETIC KIDNEY
Production of ATP occurs in the mitochondrial inner membrane.
In the electron transport system (ETS), the transferring of
electrons from complex I to IV is coupled to translocation
of protons to the intermembrane space, creating a membrane
potential that is utilized by the ATP-synthase to produce ATP.
Under normal conditions, ∼0.1–0.2% of mitochondrial oxygen
consumption is due to production of ROS (Kushnareva et al.,
2002; St-Pierre et al., 2002). ROS production varies between
different segments of the nephron where the medullary thick
ascending limb of Henle (mTAL) is the predominant site
of superoxide production in the kidney (Zou et al., 2001;
Li et al., 2002). NADPH oxidase seems to be the main
source of superoxide production in mTAL (Li et al., 2002)
and tubular flow and luminal Na+ positively correlates with
ROS production in this segment (Garvin and Hong, 2008;
Cowley et al., 2015). Hall and colleagues demonstrated a higher
total ROS production in proximal tubules compared to distal
tubules (Hall et al., 2009). Inhibition of NADPH oxidase with
apocynin revealed that the difference was attributed to higher
NADPH oxidase activity in proximal tubules. The higher ratio
of mitochondrial to nuclear volume in proximal tubules due
to the larger cell size, indicate that the basal ROS production
per mitochondrion is likely lower in proximal tubules. This fits
with the lower membrane potential (1ψm) and reduction grade
of the electron transport chain in proximal tubules (Hall et al.,
2009).
In the diabetic kidney, a large body of evidence supports
the role ROS-induced damage (reviewed in Forbes et al., 2008)
and oxidative markers such as 2-isoprostane, 8-hydroxy-2-
deoxyguanosine, nitrotyrosine, and thiobarbituric acid reactive
substances have been shown to increase in numerous studies
with experimental models of diabetes and in diabetic patients
(Broedbaek et al., 2011). In 2000, Nishikawa et al. put forward
the view that mitochondrial superoxide was the source of
oxidative stress in diabetes (Nishikawa et al., 2000). The
reasoning was that cellular hyperglycemia would promote
excessive pyruvate uptake into the mitochondria and therefore
substrates feeding electrons to the ETS, ultimately resulting in
hyperpolarization of the mitochondrial membrane and increased
superoxide production. They demonstrated that hyperglycemia
increased mitochondrial superoxide production that could be
normalized by inhibiting complex II, uncoupling mitochondrial
membrane potential by carbonyl cyanide m-chlorophenyl
hydrazone or overexpression of uncoupling protein 1 (UCP-1)
and by the addition of manganese superoxide dismutase
(mnSOD). Importantly, the normalization of mitochondrial
superoxide production prevented glucose-induced activation of
known pathways to diabetes-induced damage: protein kinase
C activation, nuclear factor kappa-light-chain-enhancer of
activated B cells (NF-κB) activation, sorbitol accumulation, and
the formation of advanced glycation end-products (Nishikawa
et al., 2000).
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Mitochondrial superoxide production is strongly regulated
by mitochondrial membrane potential (Korshunov et al., 1997;
Starkov and Fiskum, 2003; Lambert and Brand, 2004) and
many reports show that mitochondria isolated from diabetic
animals and cells cultured under hyperglycemic conditions
display increased ROS production (Raza et al., 2004; Rosca
et al., 2005; Yu et al., 2006; Quijano et al., 2007; Coughlan
et al., 2009; Munusamy and MacMillan-Crow, 2009; Chacko
et al., 2010; Sourris et al., 2012). Kidney cortex mitochondria
isolated from type 2 diabetic db/db-mice show increased
superoxide and hydrogen production that could be reduced by
a mitochondrial antioxidant (Sourris et al., 2012). In kidney
cortex of streptozotocin-induced diabetic rats, glycation of
mitochondrial proteins was associated with decreased complex
III-activity and increased superoxide production (Rosca et al.,
2005). Coughlan et al. connected glucose-derived NADH
(complex I substrate) to increased mitochondrial superoxide
production in mesangial cells from diabetic rats (Coughlan
et al., 2009). In bovine aortic endothelial cells, hyperglycemic
culture conditions resulted in increased glucose metabolism,
increased mitochondrial membrane potential, and increased
formation of superoxide and hydrogen peroxide. Reducing
mitochondrial membrane potential or inhibiting electron
transport lowered mitochondrial ROS production whereas
cells lacking mitochondria did not respond with increased
ROS formation to hyperglycemic conditions (Quijano et al.,
2007). Mitochondrial ROS production is also dependent on
mitochondrial dynamics (Yu et al., 2006). Yu et al. showed in
rat liver cells that upon high glucose exposure, mitochondria
underwent rapid fragmentation and concomitantly increased
ROS production. Inhibiting mitochondrial fragmentation
prevented the glucose induced ROS production in several cell
types (Yu et al., 2006, 2008).
Not all studies show increased mitochondrial ROS in
diabetes. Real-time imaging and systemic administration of
dihydroethidium (DHE) by Dugan et al. observed decreased
superoxide production in intact kidneys of type 1 diabetic
mice compared to control mice, also supported by electron
paramagnetic resonance data in whole kidney homogenates.
The reduced superoxide production was accompanied by hyper-
phosphorylation of pyruvate dehydrogenase that contributes to
deactivation of the enzyme. This leads to reduced conversion
of pyruvate to acetyl coenzyme A and therefore reduced
equivalents to the ETS that can reduce oxygen. The AMP-
kinase (AMPK) activator 5-Aminoimidazole-4-carboxamide
ribonucleotide (AICAR) restored the observed effects and the
authors proposed a feed-forward cycle in which decreased AMPK
activity would decrease mitochondrial biogenesis via peroxisome
proliferator-activated receptor gamma coactivator 1-alpha (PGC-
1α), a cycle that would be initiated and maintained through
decreased mitochondrial ROS production (Dugan et al., 2013).
However, DHE is prone to spontaneous oxidation and is affected
by the general oxygen metabolism and technical aspects of its use
are therefore important. Superoxide-specific DHE-metabolites
can be separated by high performance liquid chromatography but
not by its general fluorescence (Halliwell and Whiteman, 2004).
Also, cortical tubular cells in diabetic animals have increased
oxygen metabolism (Korner et al., 1994) with concomitantly
decreased kidney oxygen tension (Palm et al., 2003) which will
also affect general DHE-fluorescence even if the superoxide-
specific products are still present. In the study by Dugan
et al. measurements of ROS production were done in whole
homogenate of kidneys (Dugan et al., 2013). Structural changes in
diabetic nephropathy primarily affects the glomeruli and tubules,
sites were diabetes-induced mitochondrial ROS-production has
been reported. It may be postulated that measuring whole kidney
ROS-production is not representative of alterations at the actual
site of damage.
It has been proposed that the data in Dugan et al. (2013) can
also be explained by glucose-induced increase in mitochondrial
ROS production causing deoxyribonucleic acid (DNA) breaks
in the nucleus, activating the repair enzyme poly adenosine
diphosphate ribose polymerase (PARP). As NAD+ is a substrate
for PARP its activation concomitantly reduces the NAD+ pool,
reducing its availability for sirtuin 1, a known AMPK activator
(Nishikawa et al., 2015). Therefore, PARP-activation could result
in reduced AMPK activation creating a feed-forward loop of
reduced AMPK and decreased mitochondrial biogenesis that is
initiated by high mitochondrial ROS (Nishikawa et al., 2015).
In contrast, Al-Kafaji et al. observed increased mitochondrial
ROS with concomitant increased mitochondrial copy number
in human mesangial cells as a result of high glucose exposure.
These effects were abolished by addition of the MnSOD mimetic
manganese (III) tetrakis (4-benzoic acid) porphyrin chloride
(MnTBAP; Al-Kafaji and Golbahar, 2013).
It is important to remember that the inconclusive reports
showing both higher and lower ROS production in the kidney
in diabetes may represent a temporal effect in which the
development of diabetic nephropathy may be a series of dynamic
events where hyperglycemia may initially increase mitochondrial
superoxide production but not able to maintain it as the disease
progresses. Mitochondrial superoxide production may damage
mitochondrial DNA and ETS itself, eventually resulting in
reduced superoxide production (Xie et al., 2008; Tewari et al.,
2012). Also, mitochondrial uncoupling, covered in the next
section, may be an important mechanism to prevent excessive
mitochondrial superoxide production.
MITOCHONDRIAL UNCOUPLING—A
POTENTIALLY DETRIMENTAL
CONSEQUENCE OF INCREASED ROS
Mitochondrial uncoupling is a process in which protons are
released over the mitochondrial inner membrane independently
of ATP-synthesis. This process results in the reduction of the
mitochondrial membrane potential and therefore also decreased
mitochondrial superoxide production (Nishikawa et al., 2000;
Duval et al., 2002; Miwa and Brand, 2003; Starkov and
Fiskum, 2003). However, in order to sustain ATP-production
more electrons are transferred through the ETS and oxygen
consumption is therefore increased. As the increased respiration
is independent of ATP-production it is defined as leak-respiration
and can be observed in isolated mitochondria under state 2 or 4
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respirations or when the ATP-synthase is blocked by oligomycin.
Physiologically, mitochondrial uncoupling is mediated by UCPs
(Nicholls, 1976) that are sensitive to inhibition by purine
nucleotides (Jaburek et al., 1999; Echtay et al., 2001) but can
also be mediated by the adenine nucleotide transporter that is
sensitive to carboxyatractyloside (Shabalina et al., 2006). UCP-2 is
expressed in human kidney mitochondria (Fleury et al., 1997) as
well as in rats and mice (Jezek et al., 1999; Friederich et al., 2009).
In kidney cortex from type 1 diabetic rats UCP-2 expression was
increased, resulting in increased mitochondrial leak-respiration
that was sensitive to purine nucleotides (Friederich et al., 2008).
UCPs are proposed as the mitochondrial internal defense
system against increased ROS production and several reports
show that UCPs can be activated by superoxide (Echtay et al.,
2002; Krauss et al., 2003) as well as by lipid peroxidation
products (Echtay et al., 2003). In support, kidney cortex
mitochondria of type 2 diabetic db/db-mice displayed increased
mitochondrial leak respiration that was corrected after treatment
with the antioxidant Q10 (Persson et al., 2012). The role
of UCP-2 in regulating mitochondrial membrane potential
and therefore ROS production has been reported in several
studies. In murine endothelial cells, small interfering (si)-
RNA toward UCP-2 resulted in increased mitochondrial
membrane potential and ROS production (Duval et al., 2002).
Macrophages from UCP-2 knockout mice display increased ROS
production (Arsenijevic et al., 2000) and these mice display
increased survival and clearance rates following infections
(Arsenijevic et al., 2000; Rousset et al., 2006). In mice,
the overexpression of UCP-2 in the brain is reported to
decrease lesions and enhance neurological functions after
ischemic insults (Mattiasson et al., 2003). Interestingly, after
siRNA-mediated silencing of UCP-2 in diabetic rats it was
observed that the adenine nucleotide transporter compensated
with a further increased mitochondrial uncoupling in kidney
cortex mitochondria (Friederich-Persson et al., 2012), indicating
mitochondrial uncoupling as a mechanism of importance in the
diabetic kidney.
While some report increased mitochondrial membrane
potential with diabetes or hyperglycemic culture conditions
(Nishikawa et al., 2000; Raza et al., 2004; Rosca et al., 2005;
Yu et al., 2006; Quijano et al., 2007; Coughlan et al., 2009;
Munusamy and MacMillan-Crow, 2009; Chacko et al., 2010;
Sourris et al., 2012) not all studies do (Friederich-Persson
et al., 2012; Persson et al., 2012). Studies that did not
observe hyperpolarized mitochondria in diabetic kidneys also
show the presence of mitochondrial uncoupling and increased
mitochondrial membrane potential was only observed when
mitochondrial uncoupling was blocked (Friederich-Persson et al.,
2012; Persson et al., 2012). Thus, mitochondrial uncoupling
may be a defensive strategy in order to maintain mitochondrial
membrane potential at a normal level. Temporal effects may
also be important. Munusamy et al. cultured proximal tubular
cells under hyperglycemic condition and saw an initial increase
in mitochondrial membrane potential and increased ROS-
production. Importantly, this was followed by a second phase
with reduced mitochondrial membrane potential and ROS
production (Munusamy and MacMillan-Crow, 2009). It may
be postulated that the second phase represents the initiation of
mitochondrial uncoupling but the use of purine nucleotides or
carboxyatractyloside were not employed to probe for possible
mechanisms of leak respiration (Munusamy and MacMillan-
Crow, 2009).
While mitochondrial uncoupling can be viewed as a
mechanism protective of mitochondrial function it may be
detrimental for the kidney due to the resulting increased
oxygen consumption. The kidney is unable to correct
increased oxygen usage with increased renal blood flow
since that would increase tubular load of electrolytes destined
for active transport and therefore in itself increase oxygen
demand. Therefore, increased mitochondrial leak respiration
would cause a decrease in renal oxygen availability and it
has been suggested that diabetes-induced mitochondrial
uncoupling contributes to the low oxygen tension seen in
diabetic kidneys (Friederich-Persson et al., 2012). Indeed,
treating healthy rats with the mitochondrial uncoupler
dinitrophenol for 30 days results in kidney hypoxia, albuminuria,
and tubulointerstitial damage without affecting levels of
glycaemia or oxidative stress (Friederich-Persson et al.,
2013).
AMPK SIGNALING IN THE DIABETIC
KIDNEY
AMPK regulates anabolic processes and the AMPK activity is
dependent upon the surrounding energy levels (Hardie et al.,
2012). When AMP/ATP ratio is increased under conditions such
as hypoxia, exercise and hypoglycemia AMPK is allosterically
activated (Hardie et al., 2012). In addition, AMPK can also
be activated by upstream kinases such as the liver kinase B1
(Hawley et al., 2003) and Ca2+/calmodulin-dependent protein
kinase kinases β (Emerling et al., 2009). When activated, AMPK
contributes to the inhibition of anabolic energy-consuming
pathways and stimulates catabolic energy-producing pathways,
thus leading to increased intracellular energy levels (Hardie et al.,
2003).
In the diabetic kidney, despite renal hypoxia, AMPK is
downregulated (Dugan et al., 2013). One possibility is that the
degree of hypoxia may not be severe enough to result in AMPK-
activation. Another possibility is the role of mitochondrial ROS
production. Nishikawa recently proposed a hypothesis where
ROS-induced activation of PARP may reduce the levels of
NAD+ and thus AMPK-activity through reduced SIRT1-activity
(Nishikawa et al., 2015). Also, Emerling and colleagues reported
that hypoxic activation of AMPK is dependent on mitochondrial
ROS production rather than AMP:ATP ratios (Emerling et al.,
2009). ROS also appear to mediate calcium release from the
endoplasmic reticulum which then contributes to the formation
of CRAC channels. This contributes to amplification of the
signal through the entry of calcium that subsequently activates
Ca2+/calmodulin-dependent protein kinase kinases β that targets
AMPK (Mungai et al., 2011). On the contrary, Dugan et al.
observed decreased levels of ROS in the diabetic kidney and
suggested a feed-forward cycle of decreased AMPK, PGC-1α, and
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mitochondrial biogenesis initiated and maintained by reduced
mitochondrial ROS production (Dugan et al., 2013).
AMPK has emerged as a regulator of cellular redox state
and expression of antioxidants through the class O forkhead
box signaling pathway (Sanchez et al., 2012) that promotes cell
survival, mitochondrial biogenesis, and longevity (Fernandez-
Marcos and Auwerx, 2011; Martins et al., 2016). In response
to metabolic stress, class O forkhead box 3 is activated
by AMPK that subsequently leads to increased levels of
endogenous antioxidants such as mnSOD as well as thioredoxin,
peroxiredoxin, and catalase (Kops et al., 2002; Zrelli et al., 2011).
Therefore, AMPK activation may have the potential to attenuate
glucose-induced oxidative stress in diabetic nephropathy. The
antidiabetic and AMPK activating drug metformin lowered ROS
production, lipid peroxidation and increased the antioxidant
system in kidneys in a rat model of gentamicin toxicity (Morales
et al., 2010). HUVEC cells treated with AMPK activator AICAR
displayed decreased hyperglycemia-induced ROS production,
increased expression of PGC-1α, mnSOD, nuclear respiratory
factor-1, and mitochondrial transcription factor A together with
stimulated mitochondrial proliferation (Kukidome et al., 2006).
The conflicting literature regarding mitochondrial ROS
production in diabetes makes the relationship between
mitochondrial ROS production and AMPK activation especially
difficult to interpret. However, if mitochondrial ROS production
is increased with hyperglycemia, locally if not represented in
the whole kidney, not only would increased mitochondrial ROS
production result in mitochondrial uncoupling and contribute to
hypoxia through that pathway but also result in reduced AMPK
activation and thus fails to divert oxygen consumption from
oxidative phosphorylation to the more oxygen-saving glycolysis.
As AMPK is reported to be down-regulated in the diabetic kidney
(Dugan et al., 2013), AMPK activators may have beneficial effects
on kidney hypoxia. In cultured liver epithelial cells, metformin
suppressed hypoxia inducible factor (HIF)-1α stabilization by
decreasing cellular oxygen consumption (Minokoshi et al., 2004;
Zhou et al., 2016). No studies to date have investigated whether
AMPK-activators can affect kidney oxygenation in vivo. See
Figure 1 for summary of proposed mechanisms.
Some caution is needed regarding possible off target effects of
AMPK activators. Inhibition of hypothalamic AMPK is necessary
for leptin’s negative effects on food intake and body weight
(Minokoshi et al., 2004; Hardie, 2015) and pharmacological
AMPK activationmay therefore alter the hormonal and nutrient-
derived signals and energy balance (Hardie, 2015). Achieving
tissue specific AMPK activation would therefore be optimal in
any future AMPK-dependent treatments.
HYPOXIA INDUCIBLE FACTORS IN THE
DIABETIC KIDNEY
The oxygen dependent degradation of HIF-1α regulates the
activity of HIF-1 transcription factor complex (Chen and Sang,
2016). In normoxia, prolyl 4-hydroxylases hydroxylate HIF-1α,
enables the binding to the von-Hippel-Lindau complex and
subsequent proteosomal degradation by an E3 ubiquitin ligase
FIGURE 1 | Summary scheme of how increased mitochondrial reactive
oxygen species production (ROS) connects to decreased 5′
AMP-activated protein kinase activity. See text for further details. AMPK,
AMP-activated protein kinase; CAMK-β, Ca2+/calmodulin-dependent protein
kinase; CRAC, calcium release activated channel; ER, endoplasmic reticulum;
FOXO3, Forkhead box O3; NAD, nicotinamide adenine dinucleotide;
OX.PHOS, oxidative phosphorylation; PARP, poly (ADP-ribose) polymerase;
ROS, reactive oxygen species; QO2, oxygen consumption.
complex (Chen and Sang, 2016). The stabilization or degradation
of HIF is a swiftly regulated process. Upon reoxygenation after
hypoxia, degradation of the HIF-1α protein occurs with a half-
life of <1 min (Yu et al., 1998). Recent studies highlight
that ROS partly play a role in the stabilization of HIF-1α
(Irwin et al., 2009; Niecknig et al., 2012; Zepeda et al., 2013).
Mitochondrial ROS in particular (Brunelle et al., 2005) and
sirtuin-dependent transactivation of HIF have emerged as a
key factor (Lim et al., 2010; Zhong et al., 2010; Finley et al.,
2011; Hubbi et al., 2013). HIF-target genes include pyruvate
dehydrogenase kinase 1 (Loenarz et al., 2011) that inhibits
pyruvate dehydrogenase, reducing the entry of acetyl-coenzyme
A to the tricarboxylic acid cycle (TCA) and therefore contributes
to the hypoxia-induced switch from oxidative phosphorylation
to glycolysis. Sustained HIF-signaling also induces angiogenesis
through vascular endothelial growth factor (Conway et al.,
2001) and hematopoiesis via erythropoietin (Semenza, 1999) and
fibrotic encapsulation will occur in long-term hypoxia (Tanaka,
2017).
Systemic hypoxia leads to accumulation of HIF-1α in most
tubular segments with varied intensity, depending on the
nature of hypoxic stimulus (Rosenberger et al., 2002). By
contrast, HIF-2α is expressed in endothelial cells of a small
subset of glomeruli, peritubular endothelial cells and fibroblasts
(Rosenberger et al., 2002). Interestingly, inducing HIF by the
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hypoxia mimetic cobalt chloride mainly contributes to HIF-1α
in distal convoluted tubuli presumably related to uptake and
accumulation (Nagao et al., 1999). Induced HIF-1α expression
in the kidney has been demonstrated with diabetes in both rats
(Rosenberger et al., 2008) and humans (Higgins et al., 2007;
Shao et al., 2016) where overall HIF-signaling may contribute
to renal injury. Higgins et al. showed that genetic ablation of
epithelial HIF-1α in primary renal epithelial cells and in proximal
tubules of kidneys subjected to unilateral ureteral obstruction
inhibited the development of tubulointerstitial fibrosis, decreased
inflammatory cell infiltration and reduced the number of
fibroblast-specific protein-1-expressing interstitial cells (Higgins
et al., 2007). Renal HIF-1α expression is also associated with
tubulointerstitial injury in patients with chronic kidney disease
(Higgins et al., 2007) and increased area of renal fibrosis has
been observed in tubular epithelial cell specific von-Hippel-
Lindau knockout mice (Kimura et al., 2008). Silencing HIF-
1α with short hairpin RNA-technique significantly attenuated
levels of collagen and α-smooth muscle actin and injury in
kidneys from hypertensive rats (Wang et al., 2014). In addition,
Nayak and colleagues observed reduced whole kidney glomerular
hypertrophy, mesangial matrix expansion, extracellular matrix
accumulation and urinary albumin excretion in diabetic mice
upon treatment with the HIF-1 inhibitor YC-1 (Nayak et al.,
2016).
In contrast, Nordquist et al. found no increase in HIF-
responsive genes measured in whole kidney homogenates
after 4 weeks of streptozotocin-induced diabetes where renal
hypoxia was present (Nordquist et al., 2015). In this study
diabetes-induced renal hypoxia, proteinuria and kidney injury
were prevented by chronic HIF-activation via cobalt chloride
(Nordquist et al., 2015), highlighting the importance of
HIF-activation on regulating oxygen metabolism in diabetic
nephropathy (further highlighted in Haase, 2015). Chronic HIF-
activation has also been reported to be beneficial in an obese
hypertensive model of type 2 diabetes where cobalt chloride
did not affect metabolic parameters, obesity or hypertension but
reduced proteinuria, improved kidney histology and decreased
expression of fibrotic markers transforming growth factor β and
connective tissue growth factor (Ohtomo et al., 2008).
Interestingly, kidney cortex mitochondria from diabetic
animals in Nordquist et al. displayed mitochondrial uncoupling
that was completely prevented by HIF-activation (Nordquist
et al., 2015). In pulmonary artery smooth muscle cells,
deficiency of mitochondrial UCP-2 resulted in hyperpolarized
mitochondria, resistance to apoptosis, and reduced TCA cycle
intermediates, changes that were replicated by hypoxia in
wild type pulmonary artery smooth muscle cells. These results
were substantiated in UCP-2 knockout mice when the mice
displayed a pseudohypoxic state with increased pulmonary HIF-
1α signaling, vascular remodeling and spontaneous development
of pulmonary hypertension (Dromparis et al., 2013). It has been
shown that mitochondrial ROS contributes to the stabilization
of HIF (Brunelle et al., 2005), this through a ROS mediated
activation of p38 mitogen-activated protein kinase (Emerling
et al., 2005). However, as mitochondrial uncoupling proteins
are also activated by ROS (Echtay et al., 2002) and some
studies report normalized membrane potential in kidney cortex
mitochondria isolated from diabetic rats and mice (Friederich-
Persson et al., 2012; Persson et al., 2012) the glucose-
induced mitochondrial uncoupling may act to prevent HIF-
activation. Rosenberger et al. also observe this in a study where
HIF-signaling could be enhanced by Tempol administration
(Rosenberger et al., 2008), further suggesting an involvement
of ROS. It has also been suggested that hyperglycemia directly
interferes with HIF-signaling through hyperosmolarity as shown
in endothelial cells and dermal fibroblasts (Catrina et al., 2004).
Together, mitochondrial ROS and hyperglycemia may act to
render the HIF-activation in diabetic kidneys submaximal.
Summarizing available data, a case can be made both for and
against using chronic HIF-1α activation in diabetic nephropathy.
Disparate results may well reflect the use of different models
of diabetes but is also likely to reflect temporal aspects of HIF-
activation; how long shouldHIF-activation be sustained and early
or late in disease progression? These are just some of the issues
that should be clarified in further studies.
MITOCHONDRIAL DYNAMICS AND
MITOPHAGY IN THE DIABETIC KIDNEY
In healthy tissues, mitochondria are present in tubular networks
that are constantly reworked by mitochondrial fission and
fusion. Fission results in mitochondrial fragmentation and
production of short rods and spheres whereas fusion results in
long filamentous mitochondria. It is a highly dynamic process
(Liesa et al., 2009; Westermann, 2010) and controlled by a
set of proteins where dynamin related protein 1 (DRP1) and
mitochondrial fission 1 protein (FIS1) controls fission and
mitofusin 1–2 and optic atrophy 1 is in control of fusion (Chan,
2006).
As previously mentioned, mitochondrial dynamics is
important for glucose-induced increase in mitochondrial ROS
production (Yu et al., 2006). Wang et al. elegantly showed the
role of Rho-associated coiled coil-containing protein kinase 1
in activation and recruitment of DRP1 to mitochondria upon
high glucose stimulation, promoting mitochondrial fission,
fragmentation, and higher ROS production in podocytes (Wang
et al., 2012). High glucose exposure, expression of DRP1 and
FIS1 is induced in endothelial cells together with a loss of
the mitochondrial network (Shenouda et al., 2011). Inhibiting
DRP1 can also attenuate acute kidney injury and tubular cell
apoptosis in mice (Brooks et al., 2009). Similarly, boosting
mitochondrial fusion by overexpressing mitofusion 2 resulted in
reduced proteinuria, kidney hypertrophy and albumin:creatinine
ratio together with improved pathological changes in diabetic
rats (Pawlikowska et al., 2007). Mitochondrial fission and
concomitantly increased ROS production that contributes to
the deleterious impact on kidney function is evident in diabetes.
Thus, inhibiting fission and/or promoting fusion may impede
the progression of DN.
Selective degradation of mitochondria by the autophagic
machinery is termed mitophagy (Lemasters, 2005) and
mitochondria must undergo fragmentation into spheroids
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FIGURE 2 | Schematic summary of how increased mitochondrial reactive oxygen species (ROS) production connects to renal hypoxia and diabetic
kidney injury. High glucose results in increased mitochondrial ROS-production through glycation and damage of electron transporting complexes and an increased
load of electron donating substrates, resulting in an increased mitochondrial membrane potential. High glucose results in mitochondrial fragmentation and due to
glucose-induced alterations in mitophagy there may be an accumulation of damaged and fragmented kidney mitochondria in diabetes. Mitochondrial ROS-production
can reduce activation of 5′ AMP-activated protein kinase (AMPK), resulting in decreased antioxidant systems, creating a circle that contributes to mitochondrial
damage and perhaps further enhanced ROS-production. Decreased AMPK-activity will also fail to divert oxygen consumption (QO2)-expensive pathways such as
oxidative phosphorylation to QO2-saving pathways such as glycolysis. High glucose and increased mitochondrial ROS production will increase expression and
activation of uncoupling protein-2. The process of mitochondrial uncoupling will reduce mitochondrial membrane potential and ROS production but will concomitantly
increase mitochondrial QO2. High glucose can increase hypoxia inducible factor (HIF)-1α expression and mitochondrial ROS-production contributes to HIF activation.
Hyperosmolarity can interfere with HIF signaling and chronic activation of HIF can prevent renal hypoxia. On the other hand, various inhibitors of HIF attenuates renal
injury, raising the issue whether kidney HIF signaling is submaximal or excessive in diabetes. Differences in study results may involve methodological setup in terms of
model of diabetes or other kidney disease but also the time point of intervention. In summary, increased mitochondrial ROS-production affects pathways in manners
that can contribute to increased kidney QO2 and may therefore be an important mechanism in the development of kidney hypoxia and diabetic kidney injury. AMPK,
AMP-activated protein kinase; FAD, flavin adenine dinucleotide; H+, proton; HIF, hypoxia inducible factor; IMS, intermembrane space; NAD, nicotinamide adenine
dinucleotide; O.−2 , superoxide ion; OX.PHOS, oxidative phosphorylation; PDH, pyruvate dehydrogenase; TCA, tricarboxylic acid cycle; ROS, reactive oxygen species;
UCP, uncoupling protein; QO2, oxygen consumption.
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before being encapsulated within autophagic vesicles (Twig
et al., 2008). Dysfunctional mitochondria that have lost their
membrane potential are tagged for mitophagy clearance via the
PTEN-induced putative kinase (Matsuda et al., 2010; Vives-
Bauza et al., 2010), a serine/threonine-protein kinase located
on the mitochondrial outer membrane. PTEN-induced putative
kinase is a docking protein for parkin, a key protein to direct
damaged mitochondria for engulfment by autophagosomes
(Matsuda et al., 2010; Narendra et al., 2010; Vives-Bauza et al.,
2010; Lazarou et al., 2013).
The observed accumulation of damaged mitochondria in
the kidney in diabetes indicates impairment in the mitophagy
system (Kimura et al., 2011; Liu et al., 2012; Takahashi
et al., 2012) and autophagy has previously been linked to the
pathogenesis of diabetic nephropathy, acute kidney injury and
polycystic kidney disease (Huber et al., 2012). Sequestosome 1
(P62/SQSTM1) is an autophagy marker that correlates inversely
to autophagic flux (Vallon et al., 2013). In a rat type 2 diabetes
model, p62/SQSTM1 was increased (Kitada et al., 2011) and
reduced levels of autophagy markers were observed in mouse
glomerular lysates 28 days after streptozotocin injection (Fang
et al., 2013). Decreased staining of the autophagy marker, LC3-
phosphatidylethanolamine conjugate (LC3-II) was also observed
in podocytes from human biopsies obtained from patients with
diabetes (Fang et al., 2013). Thioredoxin interacting protein,
another mitophagy regulator, is upregulated and results in
increased ROS production, inflammation and fibrosis in the
diabetic kidney (Devi et al., 2012; Mahmood et al., 2013).
Cellular homeostasis is dependent on a dynamic balance
between fission and fusion and it is clear that in mitochondrial
dynamics and mitophagy is affected in the diabetic kidneys.
Many reports relate this to mitochondrial ROS production that
will in turn affect pathways related to kidney hypoxia such as
AMPK-signaling, HIF-activity and mitochondrial uncoupling.
Interestingly, Galloway and colleagues showed that inhibiting
mitochondrial fission in hepatocytes overexpressing dynamin
like protein (DLP-1) caused increased proton leak with a
functionally intact electron transport chain (Galloway et al.,
2012). Whether pharmacological blockade of mitochondrial
fission is beneficial in diabetic nephropathy is currently
unclear and it should be cautioned that chronic disruption of
fission might eventually induce mitochondrial dysfunction via
uncoupling, accumulation of damaged mitochondria, and cell
injury.
SUMMARY AND CONCLUSIONS
The development of diabetic nephropathy is likely to
represent a series of dynamic events. Many studies report
altered mitochondrial function in the diabetic kidney. These
alterations include altered mitophagy, mitochondrial dynamics,
mitochondrial uncoupling, and signaling through AMPK and
HIF. Herein, we have discussed how these pathways may relate
to mitochondrial ROS production in the diabetic kidney. In
experimental models, correcting mitochondrial ROS production
reduces albuminuria in diabetic mice (Sourris et al., 2012)
and preventing ROS induced mitochondrial leak-respiration
improves kidney function (Persson et al., 2012). However,
a recent phase 3 study where the nuclear respiratory factor
2-inducer bardoxolone methyl was used for targeting diabetic
nephropathy failed to improve the outcome of end-stage
renal disease or cardiovascular mortality. Instead, increased
albuminuria, heart-failure, and hypertension in patients with
advanced diabetic nephropathy contributed to early termination
of the study (de Zeeuw et al., 2013).
Many of the discussed factors are intertwined in a complex
manner, making it very difficult to highlight a specificmechanism
in the diabetic kidney. Partly underlying the difficulty of
highlighting a specific mechanism is the functional heterogeneity
of the kidney. Different segments have different function and
surrounding oxygen levels, different levels of the discussed
cellular pathways and different sources and levels of ROS
production. However, from available literature it seems clear
that mitochondrial ROS production may be a joint mechanism.
The resulting effects on mitochondrial and cellular pathways
affecting oxygen metabolism may play an important role in the
development of diabetic nephropathy. For a schematic summary,
see Figure 2. The correction and/or prevention of mitochondrial
dysfunction may be pivotal in the prevention and treatment of
diabetic nephropathy.
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